| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | UNITEDHEALTH GROUP INC | 130,000 | 18,200,000 | 2.89% | ||
| 102 | ALLERGAN PLC | 79,500 | 18,309,645 | 2.91% | ||
| 103 | Pfizer Inc | 555,355 | 18,809,874 | 2.99% | ||
| 104 | CELGENE CORP | 186,000 | 19,442,580 | 3.09% | ||
| 105 | ALEXION PHARMACEUTIC | 161,702 | 19,814,963 | 3.15% | ||
| 106 | LILLY ELI & CO | 255,000 | 20,466,300 | 3.25% | ||
| 107 | SHIRE PLC | 409,858 | 26,595,290 | 4.22% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-007347, filed 2016.11.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.